Literature DB >> 9613635

Use of DNA fingerprinting for primary surveillance of nosocomial tuberculosis in a large urban hospital: detection of outbreaks in homeless people and migrant workers.

N Lemaître1, W Sougakoff, C Truffot-Pernot, E Cambau, J P Derenne, F Bricaire, J Grosset, V Jarlier.   

Abstract

SETTING: A large urban teaching hospital in the southeast of Paris.
OBJECTIVE: Primary surveillance of nosocomial transmission of tuberculosis (TB) by systematic restriction fragment length polymorphism analysis (RFLP) of isolates (n = 161) recovered from smear-positive pulmonary TB patients identified from 1 March 1993 to 28 February 1994, and from all TB patients (with any form of tuberculous infection) identified from 1 March 1994 to 30 April 1995.
RESULTS: Systematic RFLP analysis revealed 12 clusters of patients (n = 40) infected by strains of Mycobacterium tuberculosis showing matching RFLP patterns. None of the isolates were multidrug-resistant. Compared with non-clustered patients, clustered patients were more likely to be homeless (55% vs 19%, P < or = 0.001), or Africans living in hostels for migrant workers (20% vs 6%, P = 0.01), and had fewer previous admissions to hospital (12% vs 28%, P = 0.05). Further epidemiological investigations showed that the clustered TB cases actually resulted not from nosocomial transmission, but from transmission in the community, very likely in homeless shelters and hostels for migrant workers.
CONCLUSION: No nosocomial transmission of TB was identified among the patients included during the study period. Systematic RFLP analysis using hospital-based sampling can detect the spread of TB in specific environments in the community where transmission is occurring.

Entities:  

Mesh:

Year:  1998        PMID: 9613635

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  6 in total

1.  Strain-specific differences in two large Mycobacterium tuberculosis genotype clusters in isolates collected from homeless patients in New York City from 2001 to 2004.

Authors:  Michelle Macaraig; Tracy Agerton; Cynthia R Driver; Sonal S Munsiff; Jalaa' Abdelwahab; Julie Park; Barry Kreiswirth; Jeffrey Driscoll; Benyang Zhao
Journal:  J Clin Microbiol       Date:  2006-08       Impact factor: 5.948

2.  Restriction fragment length polymorphism analysis of Mycobacterium tuberculosis isolated from countries in the western pacific region.

Authors:  Y K Park; G H Bai; S J Kim
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

3.  A combination of two genetic markers is sufficient for restriction fragment length polymorphism typing of Mycobacterium tuberculosis complex in areas with a high incidence of tuberculosis.

Authors:  V Rasolofo-Razanamparany; H Ramarokoto; G Aurégan; B Gicquel; S Chanteau
Journal:  J Clin Microbiol       Date:  2001-04       Impact factor: 5.948

4.  Tuberculosis among homeless population from Medellín, Colombia: associated mental disorders and socio-demographic characteristics.

Authors:  José Mauricio Hernández Sarmiento; Nidia Correa; Marta Correa; José Gabriel Franco; Matilde Alvarez; Clara Ramírez; Lina M Gómez; Antonio Carlos Toro; Nora Helena Londoño; Milton Martínez; Mary Alejandra Restrepo; Elsa Zapata; Gloria Isabel Mejía; Jaime Robledo
Journal:  J Immigr Minor Health       Date:  2013-08

5.  Occupational risk of tuberculosis transmission in a low incidence area.

Authors:  Roland Diel; Andreas Seidler; Albert Nienhaus; Sabine Rüsch-Gerdes; Stefan Niemann
Journal:  Respir Res       Date:  2005-04-14

6.  Multiplexed Quantitation of Intraphagocyte Mycobacterium tuberculosis Secreted Protein Effectors.

Authors:  Fadel Sayes; Catherine Blanc; Louis S Ates; Nathalie Deboosere; Mickael Orgeur; Fabien Le Chevalier; Matthias I Gröschel; Wafa Frigui; Ok-Ryul Song; Richard Lo-Man; Florence Brossier; Wladimir Sougakoff; Daria Bottai; Priscille Brodin; Pierre Charneau; Roland Brosch; Laleh Majlessi
Journal:  Cell Rep       Date:  2018-04-24       Impact factor: 9.423

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.